As the incidence of genetic disorders increases, there is a corresponding rise in the demand for molecular biology enzymes, kits, and reagents essential for conducting tests. These tools are vital for ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

Inc. (NYSE: BIO and BIO.B), a $8.49 billion market cap company known for its life science research and clinical diagnostics products, has announced plans to acquire Stilla Technologies, a developer of ...

Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics products, today announced that the company has entered into a binding offer to purchase all equity ...

Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.